Skip to content

Effect of treat to target in psoriatic arthritis (TOPA): a single centre, open-label, randomized controlled trial

Effect of treat to target in psoriatic arthritis (TOPA): a single centre, open-label, randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000030793
Enrollment
Unknown
Registered
2020-03-14
Start date
2020-04-01
Completion date
Unknown
Last updated
2020-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

psoriatic arthritis

Interventions

treat-to-traget group:Take the minimal disease activity (MDA) as the treatment target
control group:conventional therapy

Sponsors

Beijing University First Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1) Satisfy the Classification Criteria for Psoriatic Arthritis (CASPAR criteria). 2) Age between 18 and 75 years. 3) Active psoriatic arthritis (defined as symptoms at an unacceptably bothersome level as reported by the patient and judged by the examining health care provider to be due to PsA based on the presenceof at least 1 of the following: actively inflamed joints, dactylitis,enthesitis, axial disease, active skin and/or nail involvement,and/or extraarticular manifestations such as uveitis or inflammatorybowel disease (IBD). 4) Agree to participate in the study and sign informed consent.

Exclusion criteria

Exclusion criteria: 1) Pregnancy, lactation or pregnancy planner within the next 2 years. 2) Psoriatic arthritis with psoriatic spondylitis/axial disease asthe main manifestation. 3) Other situations that the clinician determines are not suitable for participation.

Design outcomes

Primary

MeasureTime frame
ACR50;

Secondary

MeasureTime frame
Disease activity index for Psoriatic Arthritis;Psoriatic Area Severity inedx;Quality of life;the modified Sharp-van der Heijde score;musculosketal ultrasound;adverse events;ACR20/70;

Countries

China

Contacts

Public ContactZhuoli Zhang

Beijing University First Hospital

zhuoli.zhang@126.com+86 010-83572064

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026